Literature DB >> 24686080

ER stress signaling in ARPE-19 cells after inhibition of protein kinase CK2 by CX-4945.

Johanna Intemann1, Nathaniel Edward Bennett Saidu1, Lisa Schwind1, Mathias Montenarh2.   

Abstract

Protein kinase CK2 is a critical factor for the survival of cells. It is overexpressed in many cancer cells and provides protection against apoptosis in these cells. Inhibition of CK2 kinase activity in various cancer cells leads to apoptosis, which makes CK2 an attractive target for cancer therapy. Little is, however, known about CK2 inhibition in non-cancerous cells. Using the human retinal pigment epithelial cell line ARPE-19, we analyzed the formation of reactive oxygen species (ROS) and the ER stress signaling pathway after CK2 inhibition with CX-4945. Following CK2 inhibition, we did not find any significant generation of ROS in neither ARPE-19 non-cancer cells nor in HCT116 cancer cells. We found an induction of the ER stress pathway including the activation of eIF2α and ATF4 in both cell types. This activation was sufficient for ARPE-19 cells to cope with the ER stress. Furthermore, in contrast to HCT116 cancer cells, there was no induction of the pro-apoptotic transcription factor CHOP and no induction of apoptosis in the ARPE-19 cells. Overexpression of CHOP, however, induced apoptosis in ARPE-19 cells indicating that this step in the ER stress pathway is abrogated in normal cells compared to cancer cell.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; CHOP; ER stress; Growth arrest; Protein kinase

Mesh:

Substances:

Year:  2014        PMID: 24686080     DOI: 10.1016/j.cellsig.2014.03.014

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  12 in total

1.  Protein kinase CK2 in development and differentiation.

Authors:  Claudia Götz; Mathias Montenarh
Journal:  Biomed Rep       Date:  2016-12-19

Review 2.  Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells.

Authors:  Inge M N Wortel; Laurens T van der Meer; Michael S Kilberg; Frank N van Leeuwen
Journal:  Trends Endocrinol Metab       Date:  2017-08-07       Impact factor: 12.015

3.  Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma.

Authors:  Anne S Boewe; Silke Wemmert; Philipp Kulas; Bernhard Schick; Claudia Götz; Selina Wrublewsky; Mathias Montenarh; Michael D Menger; Matthias W Laschke; Emmanuel Ampofo
Journal:  Biomedicines       Date:  2022-04-21

4.  Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.

Authors:  Christian Posch; Martina Sanlorenzo; Igor Vujic; Juan A Oses-Prieto; Brian D Cholewa; Sarasa T Kim; Jeffrey Ma; Kevin Lai; Mitchell Zekhtser; Rosaura Esteve-Puig; Gary Green; Shreya Chand; Alma L Burlingame; Renate Panzer-Grümayer; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  J Invest Dermatol       Date:  2016-05-29       Impact factor: 8.551

5.  Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.

Authors:  Qianwen Li; Yan Zong; Ke Li; Xiaohua Jie; Jiaxin Hong; Xiaoshu Zhou; Bian Wu; Zhenyu Li; Sheng Zhang; Gang Wu; Rui Meng
Journal:  Biol Res       Date:  2019-04-16       Impact factor: 5.612

6.  Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells.

Authors:  Lucía Villamañan; Laura Martínez-Escardó; Carles Arús; Victor J Yuste; Ana P Candiota
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

7.  4,5,7-Trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects.

Authors:  Robin Birus; Ehab El-Awaad; Laurens Ballentin; Faten Alchab; Dagmar Aichele; Laurent Ettouati; Claudia Götz; Marc Le Borgne; Joachim Jose
Journal:  FEBS Open Bio       Date:  2021-12-18       Impact factor: 2.693

8.  Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination.

Authors:  Maria Cosenza; Monica Civallero; Luigi Marcheselli; Stefano Sacchi; Samantha Pozzi
Journal:  Apoptosis       Date:  2020-06       Impact factor: 4.677

Review 9.  Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Mathias Montenarh; Claudia Götz
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

10.  SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells.

Authors:  Mandy Pack; Claudia Götz; Selina Wrublewsky; Mathias Montenarh
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.